Evidence map›Paper›PMID 35877987›Full record

ArticleAIDS care2022

Experiences of participants in a decentralized antiretroviral therapy program in South Africa during the COVID-19 pandemic.

Jana Jarolimova, Joyce Yan, Sabina Govere, Bridget A Bunda, Nafisa J Wara, Laura M Bogart, Nompumelelo Ngobese, Zinhle M Shazi, Anele R Khumalo, Dani Zionts and 3 more

Open access · hybridAbstract read
In one paragraph

Article in AIDS care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Jana JarolimovaMassachusetts General Hospital, Division of Infectious Diseases, Boston, United States.
Joyce YanMassachusetts General Hospital, Biostatistics Center, Boston, United States.
Sabina GovereAIDS Healthcare Foundation, Durban, South Africa.
Bridget A BundaMassachusetts General Hospital, Medical Practice Evaluation Center, Boston, United States.
Nafisa J WaraMassachusetts General Hospital, Medical Practice Evaluation Center, Boston, United States.
Laura M BogartRAND Corporation, Santa Monica, United States.
Nompumelelo NgobeseAIDS Healthcare Foundation, Durban, South Africa.
Zinhle M ShaziAIDS Healthcare Foundation, Durban, South Africa.
Anele R KhumaloAIDS Healthcare Foundation, Durban, South Africa.
Dani ZiontsMassachusetts General Hospital, Medical Practice Evaluation Center, Boston, United States.
Hilary ThulareAIDS Healthcare Foundation, Durban, South Africa.
Robert A ParkerMassachusetts General Hospital, Biostatistics Center, Boston, United States.
Ingrid V BassettMassachusetts General Hospital, Division of Infectious Diseases, Boston, United States.
AIDS Healthcare Foundation · ZAMassachusetts General Hospital · USJohns Hopkins University Center for AIDS ResearchRAND Corporation · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
South Africa's new Central Chronic Medicine Dispensing and Distribution program: assessing the clinic, patient, and community impactR01MH114997 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BASSETT, INGRID VALERIE · 2018 to 2022
$3.4M
Mentoring in patient-oriented research on HIV prevention in the US and South AfricaK24AI141036 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Ingrid Valerie Bassett · 2019 to 2026
$1.1M
NIAID NIH HHS K24 AI141036NIAID NIH HHS T32 AI007433NIMH NIH HHS P30 MH058107NIMH NIH HHS R01 MH114997
6 · The paper itself

Abstract

The COVID-19 pandemic and associated restrictions could adversely affect long-term HIV care. We evaluated the experiences of people receiving antiretroviral therapy (ART) through a decentralized delivery program in South Africa during the COVID-19 pandemic. We telephoned a random subsample of participants enrolled in a prospective cohort study in KwaZulu-Natal in April and May 2020 and administered a semi-structured telephone interview to consenting participants. We completed interviews with 303 of 638 contacted participants (47%); 66% were female, with median age 36y. The most common concerns regarding the COVID-19 pandemic were food running out (121, 40%), fear of becoming infected with COVID-19 (103, 34%), and being unable to work/losing employment or income (102, 34%). Twenty-five (8%) participants had delayed ART pick-up due to the pandemic, while 212 (70%) had new concerns about ART access going forward. Mental health scores were worse during the pandemic compared to baseline (median score 65.0 vs 80.0,

Indexed as

COVID-19HIV InfectionsAdultAnti-Retroviral AgentsFemaleHumansMalePandemicsProspective StudiesSouth AfricaAnti-Retroviral Agentsbarriers to careCOVID-19differentiated service deliveryHIVmental healthSouth Africa

Identifiers

PMID35877987
PMCPMC9873830
OpenAlexW4287578460

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.